Navigation Links
NxStage® Advances Global Growth Strategy with System One™ Regulatory Approval and Distribution Agreement in Australia and New Zealand
Date:5/4/2011

in this region.  With increased strategic focus, we expect international to be a more meaningful driver of our long term growth beyond 2011."

The announcement of the distribution agreement with RHCG comes one week after NxStage announced that it had named Michael Miller, Jr. to the newly-created position of President, International.

About NxStage

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at www.nxstage.com.

About Regional Health Care Group

Regional Health Care Group (RHCG) is 100% Australian-owned.  RHCG is a provider of premium quality capital equipment and medical consumables, with business extending across the Australian continent and New Zealand.  RHCG are specialists in introducing innovative technology and devices to the Australian and New Zealand healthcare market. For more information on RHCG, please visit the company's website at www.rhcg.com.au.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. The forward-looking statements in this release include statements as to NxStage's expectations that international sales will be a more meaningful driver of the Company's long
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NxStage® Expands Product Portfolio With Innovative Patient Access Surveillance Solution From Vasc-Alert™
2. First NxStage® Home Hemodialysis Patients Celebrate Seven-Year Anniversary
3. NxStage® Appoints Nancy J. Ham to Its Board of Directors and Announces Resignation of Board Member Jonathan T. Silverstein
4. NxStage® to Report Fourth Quarter and Full Year 2010 Financial Results
5. NxStage® Reports Fourth Quarter and Full-Year 2010 Financial Results; Revenue Growth Exceeds Company Guidance
6. In Celebration of the 31st Annual Dialysis Conference, NxStage® Announces Over 5,000 Patients Using the System One™ for Home Hemodialysis
7. New NxStage® FREEDOM Data Shows Continued, Marked Benefits for Patients Using the System One™ for Daily Home Hemodialysis Throughout a 12 Month Period
8. NxStage® to Report First Quarter Fiscal 2011 Financial Results
9. NxStage® Names Michael Miller, Jr. President, International
10. Chronic Disease Research Group Study Shows Daily Home Hemodialysis Therapy with the NxStage® System One™ is Associated with Lower Risk of Mortality and Higher Survival Estimates Compared to Conventional Thrice-Weekly Dialysis
11. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... March 2, 2015 Following announcements from ... transactions, Array BioPharma Inc. (NASDAQ:  ARRY) today announced ... definitive agreements with Novartis.  Along with global ownership ... payment of $85 million from Novartis. ... the close of the Novartis-GSK transaction, Array now ...
(Date:3/2/2015)... NEW YORK , March 2, 2015  Delcath ... pharmaceutical and medical device company focused on oncology with ... liver cancers, announces that Company management will participate in ... held from March 8-11, 2015 at the Ritz Carlton ... Jennifer Simpson , PhD, MSN, CRNP, Delcath,s ...
(Date:3/2/2015)... According to statistics released by the American Society of Plastic ... such as the JUVEDERM ® family of fillers continues ... 2013 to 2014, HA filler treatments increased by 8 percent. ... shows U.S. unit sales of HA dermal fillers were up ... findings are consistent with what I see every day in ...
Breaking Medicine Technology:Array Announces Completion Of Binimetinib And Encorafenib Transactions 2Array Announces Completion Of Binimetinib And Encorafenib Transactions 3Array Announces Completion Of Binimetinib And Encorafenib Transactions 4Array Announces Completion Of Binimetinib And Encorafenib Transactions 5Delcath To Present At The 27th Annual Roth Conference 2Delcath To Present At The 27th Annual Roth Conference 3Demand For Hyaluronic Acid Facial Fillers In The U.S. Increases By 8 Percent 2Demand For Hyaluronic Acid Facial Fillers In The U.S. Increases By 8 Percent 3Demand For Hyaluronic Acid Facial Fillers In The U.S. Increases By 8 Percent 4Demand For Hyaluronic Acid Facial Fillers In The U.S. Increases By 8 Percent 5Demand For Hyaluronic Acid Facial Fillers In The U.S. Increases By 8 Percent 6Demand For Hyaluronic Acid Facial Fillers In The U.S. Increases By 8 Percent 7
... Corporation, a leading developer of whole blood analyzers, today ... CBGM, LLC, has completed the acquisition of certain assets ... , Nova Biomedical is the sole manufacturer, ... (CBGM) subsidiary has become the exclusive distributor, of the ...
... Oct. 7 DATATRAK International, Inc. (OTCQX: DATA), a technology ... clinical trials industry, today announced the signing of a new ... use of a thoracic stent graft in aneurysm repair. ... use of minimally invasive surgical techniques for thoracic aortic aneurysms. ...
Cached Medicine Technology:Subsidiary of Nova Biomedical Completes Acquisition of Assets of CCS Medical's Subsidiary, Sanvita, Inc. 2DATATRAK Signs 6 Year Study with New Device Client 2DATATRAK Signs 6 Year Study with New Device Client 3
(Date:3/2/2015)... 02, 2015 After a rigorous evaluation ... service, pricing and long-term strategy, Blood Centers of America ... choice for member centers’ testing needs. , BCA, which ... more than 30 percent of the U.S. blood supply, ... “BCA is committed to drive cost savings to members,” ...
(Date:3/2/2015)... York, New York (PRWEB) March 02, 2015 ... Creative Recovery at Recovery Unplugged™—will be delivering a ... A Singer/Songwriter's Perspective on the Art of Healing ... Addiction Disorders (NCAD) and Behavioral Healthcare Executive Summit ... his name, Mr. Supa’s songs have been recorded ...
(Date:3/2/2015)... the last five years the ultrasound market has witnessed ... geographic presence and achieve economies of scale. The global ... 2019 at CAGR of 5.1% from 2014 to 2019 ... a major part of Europe are mature markets for ... China and India, Latin America and the Middle East ...
(Date:3/2/2015)... The minimally invasive surgical instruments ... of 6.1% to reach $14,133.0 million by 2019 ... such as advantages of minimally invasive surgeries over ... minimally invasive surgeries and increasing number of surgical ... global minimally invasive surgical instruments market. , For ...
(Date:3/2/2015)... 02, 2015 LegitScript, LLC, ... certification programs, including those for Internet pharmacy ... safety and classification, has launched a certification ... The new program, called iCareRx , ... regarding the identity of the owner/operator of ...
Breaking Medicine News(10 mins):Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 3Health News:Richie Supa Announced as a Plenary Speaker at NCAD 2015 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 3Health News:Minimally Invasive Surgical Instrument Market - Global Forecast to 2019 - New Report by MarketsandMarkets 2Health News:LegitScript Launches Certification Program for Internet Eyeglass Sellers 2
... announced the discovery of another gene responsible for late-onset ... the disease (occurring in around 90 percent of patients) ... Boston University, the University of Toronto, and Columbia University ... in Nature Genetics. ,The reasearchers spent ...
... oral chemotherapy in US cancer centres need to be improved, ... ,Common malignancies can be treated with oral chemotherapy – a ... ,Researchers from Boston set out to analyse ... the provision of oral chemotherapy. Forty-two centres took part in ...
... research team works on understanding the heart's natural ... Cardiac Electrophysiology Lab, //she is a faculty member ... subtle rhythms, pulses and patterns of the human ... for millennia, yet the heart's deepest secrets remain ...
... rest on the couch to recover before returning to sports, ... at least not yet. // ,One Ohio State University ... devices for the heart will be put to use temporarily ... Right now, such heart pumps, known commonly as ventricular assist ...
... exposure may differ across Australia, a senior cancer researcher has ... for the production of vitamin D, which is necessary for ... prevention of several cancers. ,Australians are becoming ... out of the sun to avoid skin cancer and getting ...
... Kennedy Center for Research on Human Development has observed ... behavioral //and neurological problems in the child. ,In ... Stanwood, Ph.D., and Pat Levitt, Ph.D., have elaborated about ... which caused a prolonged displacement of dopamine receptors in ...
Cached Medicine News:Health News:New Gene to Help in Understanding Alzheimer’s Diseas 2Health News:Secrets of the Heart's Signals 2Health News:Pumps Someday May Allow Patients to Recover Their Own Hearts 2Health News:Pumps Someday May Allow Patients to Recover Their Own Hearts 3Health News:Safe Sun Exposure a Burning Issue 2Health News:Cocaine During Pregnancy can Cause Behavioral and Neurological Problems in the Child 2Health News:Cocaine During Pregnancy can Cause Behavioral and Neurological Problems in the Child 3
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTN/1Q-CAB chairs are recommended for the ... room, static control, health care and ...
... chairs with concave seats and standard-sized ... options like seats, backrests, armrests, and ... are recommended for the following environments: ... control, health care and office. • ...
... with concave seats and standard-sized backrests ... like seats, backrests, armrests, and casters ... recommended for the following environments: industry, ... health care and office. • With ...
... with concave seats and standard-sized backrests ... like seats, backrests, armrests, and casters ... recommended for the following environments: industry, ... health care and office. • With ...
Medicine Products: